Laura Hamill

Companies

• Fate TherapeuticsBoard member Jun 15, 2026 to now¹
• Jazz PharmaceuticalsBoard member Jul 30, 2024 to now²
• Y-mAbs Therapeutics, Inc.Board member Jun 18, 2020 to now³
• PARDES BIOSCIENCES, INC.Board member Dec 27, 2021 to Aug 31, 2023⁴
• Scilex Holding CoBoard member Nov 15, 2022 to Jan 17, 2023⁵
• ANAPTYSBIO, INCBoard member Sep 26, 2019 to Jan 10, 2023⁶
• Acceleron PharmaBoard member Sep 17, 2020 to Nov 22, 2021⁷
• Gilead SciencesEVP, Worldwide Commercial Ops Sep 18, 2018 to May 10, 2019⁸

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• JPJazz Pharmaceuticals JAZZ6,832 shares⁹$1.5M at $214.42Aug 31, 2026
• APAcceleron Pharma XLRN0 shares¹⁰Nov 19, 2021
• YMY-mAbs Therapeutics, Inc.0 shares¹¹Sep 16, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 31, 2026Shares withheld for tax 1,692 shares at $241.39 of Jazz Pharmaceuticals⁹
• Aug 31, 2026Shares withheld for tax 14 shares at $244.06 of Jazz Pharmaceuticals⁹
• Aug 5, 2026Granted 1,605 shares of Jazz Pharmaceuticals¹²
• Sep 16, 2025Returned to company 25,080 shares of Y-mAbs Therapeutics, Inc.¹¹
• Sep 16, 2025U 5,825 shares at $8.60 of Y-mAbs Therapeutics, Inc.¹¹
• Aug 8, 2025Shares withheld for tax 1,805 shares at $111.25 of Jazz Pharmaceuticals¹³
• Aug 7, 2025Granted 3,507 shares of Jazz Pharmaceuticals¹³
• Jun 30, 2025Granted 25,080 shares of Y-mAbs Therapeutics, Inc.¹⁴
• Aug 2, 2024Granted 3,731 shares of Jazz Pharmaceuticals¹⁵
• Jun 11, 2024Granted 3,495 shares of Y-mAbs Therapeutics, Inc.¹⁶
• Jun 8, 2023Granted 2,330 shares of Y-mAbs Therapeutics, Inc.¹⁷
• Nov 19, 2021U 474 shares of Acceleron Pharma¹⁰